2 stories mentioning HKG:2185Updated 2d ago
Every FINWIRES story that references HKG:2185, newest first.
Shanghai Bio-heart Biological Technology (HKG:2185) said China's National Medical Products Administration approved its bioabsorbable drug-eluting stent, according to a Thursday filing with the Hong Kong bourse.The company markets the stent under the Bioheart brand name.
Shanghai Bio-heart Biological Technology (HKG:2185) said its Iberis medical device to treat high blood pressure completed its registration in Vietnam, according to a Monday filing with the Hong Kong bourse.The medical device firm's shares fell over 2% in morning trade Tuesday.The device, developed by unit Shanghai AngioCare Medical Technology, was supported jointly by Biosensors International Group in Thailand.
